Ultrasound AI Secures U.S. Patent for AI-Driven Clinical Value Determination
Ultrasound AI has secured a new U.S. patent for its AI-driven system that determines clinical values from medical images, announced in a press release. This patent, titled "Artificial Intelligence System for Determining Clinical Values through Medical Imaging," adds to the company's growing portfolio, which now includes six patents across three countries.
The newly issued patent protects Ultrasound AI's proprietary technology that predicts quantitative clinical and laboratory values directly from non-invasive medical images such as ultrasound. This advancement follows the company's recently published PAIR Study, which demonstrated high accuracy in predicting delivery timing using ultrasound images.
With this latest patent, Ultrasound AI continues to strengthen its position in the field of AI-powered medical imaging, aiming to transform obstetric care and beyond with scalable, image-only AI solutions.
We hope you enjoyed this article.
Consider subscribing to one of our newsletters like Life AI Weekly or Daily AI Brief.
Also, consider following us on social media:
More from: Life Sciences
Subscribe to Life AI Weekly
Weekly coverage of AI applications in healthcare, drug development, biotechnology research, and genomics breakthroughs.
Whitepaper
Stanford HAI’s 2025 AI Index Reveals Record Growth in AI Capabilities, Investment, and Regulation
The 2025 AI Index by Stanford HAI provides a comprehensive overview of the global state of artificial intelligence, highlighting significant advancements in AI capabilities, investment, and regulation. The report details improvements in AI performance, increased adoption in various sectors, and the growing global optimism towards AI, despite ongoing challenges in reasoning and trust. It serves as a critical resource for policymakers, researchers, and industry leaders to understand AI's rapid evolution and its implications.
Read more